Sandra H. Thomas - Concepedia

Author

Sandra H. Thomas

Also Known As

Armando Lindner, David Colcher, Prague Luft, S H Thomas, S Thomas, S. H. L. Thomas, S. H. Thomas, S. H.L. Thomas, S. THOMAS, S. Thomas

158

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

City of Hope City Of Hope National Medical Center Kaiser Permanente Beckman Research Institute St Thomas' Hospital

About

Sandra H. Thomas is an author at City of Hope specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	882
2	Health Sciences	5	5	305
3	Engineering	1	1	56
4	Anesthesia	1	1	56
5	Biomedical Engineering	1	1	56

Sandra H. Thomas

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL Xiuli Wang, Leslie Popplewell, Jamie R. Wagner, Blood	2016	326
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors Anthony K. Park, Yuman Fong, Sang‐In Kim, Science Translational Medicine	2020	242
CD30 Downregulation, MMAE Resistance, and <i>MDR1</i> Upregulation Are All Associated with Resistance to Brentuximab Vedotin Robert Chen, Jessie Hou, Edward M. Newman, Molecular Cancer Therapeutics ImmunologyPathologyPharmacotherapyImmunotherapyTumor Biology	2015	202
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma Xiuli Wang, Miriam Walter, Ryan Urak, Clinical Cancer Research	2017	184
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma Robert Chen, Joycelynne Palmer, Peter Martin, Biology of Blood and Marrow Transplantation Relapsed/refractory Hodgkin LymphomaImmunologyPathologyAutologous TransplantationImmunotherapy	2015	149
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma Robert Chen, Joycelynne Palmer, Sandra H. Thomas, Blood	2012	131
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis Sepideh Shayani, Joycelynne Palmer, Tracey Stiller, Biology of Blood and Marrow Transplantation Gvhd ProphylaxisImmunologyTransplantation MedicinePathologyActive Agvhd	2012	107
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia Anthony S. Stein, Joycelynne Palmer, Ni‐Chun Tsai, Biology of Blood and Marrow Transplantation Hematological MalignancyCell TherapyTransplantationMarrow TransplantationRadiation Therapy	2017	95
Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy Ryan Urak, Miriam Walter, Laura Lim, Journal for ImmunoTherapy of Cancer	2017	95
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies Joseph Rosenthal, Jeffrey Y.C. Wong, Anthony S. Stein, Blood	2010	90

Page 1